INNOVIVA, INC. Basic Shares Outstanding (Weighted Average)
INNOVIVA, INC. (INVA) reported Basic Shares Outstanding (Weighted Average) of 73.42 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- INNOVIVA, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 73.42M shares, a 16.79% increase year-over-year.
- INNOVIVA, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 74.16M shares, a 18.26% increase year-over-year.
- INNOVIVA, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 74.88M shares, a 19.56% increase year-over-year.
- INNOVIVA, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 69.06M shares, a 10.37% increase year-over-year.
- INNOVIVA, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 67.39M shares, a 7.44% increase from fiscal 2024.
- INNOVIVA, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 62.73M shares, a 4.14% decline from fiscal 2023.
- INNOVIVA, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 65.44M shares, a 6.04% decline from fiscal 2022.
- INNOVIVA, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 69.64M shares, a 15.13% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 73.42M shares 10-Q · filed 2026-08-05 | 73.79M shares 10-Q · filed 2026-08-05 | 74.15M shares derived: average of 3 quarters · filed 2026-08-05 | 72.88M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 74.16M shares 10-Q · filed 2026-05-06 | 74.52M shares derived: average of 2 quarters · filed 2026-05-06 | 72.70M shares derived: average of 3 quarters · filed 2026-05-06 | 70.24M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 74.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 71.97M shares derived: average of 2 quarters · filed 2026-02-25 | 68.93M shares derived: average of 3 quarters · filed 2026-08-05 | 67.39M shares 10-K · filed 2026-02-25 |
| 2025-09-30 | 69.06M shares 10-Q · filed 2025-11-05 | 65.96M shares derived: average of 2 quarters · filed 2026-08-05 | 64.90M shares 10-Q · filed 2025-11-05 | 64.31M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 62.87M shares 10-Q · filed 2026-08-05 | 62.79M shares 10-Q · filed 2026-08-05 | 62.73M shares derived: average of 3 quarters · filed 2026-08-05 | 62.69M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 62.71M shares 10-Q · filed 2026-05-06 | 62.67M shares derived: average of 2 quarters · filed 2026-05-06 | 62.63M shares derived: average of 3 quarters · filed 2026-05-06 | 62.61M shares derived: average of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | 62.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 62.60M shares derived: average of 2 quarters · filed 2026-02-25 | 62.57M shares derived: average of 3 quarters · filed 2026-02-25 | 62.73M shares 10-K · filed 2026-02-25 |
| 2024-09-30 | 62.57M shares 10-Q · filed 2025-11-05 | 62.55M shares derived: average of 2 quarters · filed 2025-11-05 | 62.76M shares 10-Q · filed 2025-11-05 | 62.99M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | 62.53M shares 10-Q · filed 2025-08-06 | 62.86M shares 10-Q · filed 2025-08-06 | 63.13M shares derived: average of 3 quarters · filed 2026-02-25 | 63.59M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | 63.19M shares 10-Q · filed 2025-05-07 | 63.44M shares derived: average of 2 quarters · filed 2026-02-25 | 63.94M shares derived: average of 3 quarters · filed 2026-02-25 | 64.29M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | 63.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 64.32M shares derived: average of 2 quarters · filed 2026-02-25 | 64.66M shares derived: average of 3 quarters · filed 2026-02-25 | 65.44M shares 10-K · filed 2026-02-25 |
| 2023-09-30 | 64.95M shares 10-Q · filed 2024-11-06 | 65.15M shares derived: average of 2 quarters · filed 2024-11-06 | 66.02M shares 10-Q · filed 2024-11-06 | 66.93M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | 65.34M shares 10-Q · filed 2024-07-31 | 66.56M shares 10-Q · filed 2024-07-31 | 67.59M shares derived: average of 3 quarters · filed 2025-02-26 | 68.13M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | 67.79M shares 10-Q · filed 2024-05-08 | 68.72M shares derived: average of 2 quarters · filed 2025-02-26 | 69.06M shares derived: average of 3 quarters · filed 2025-02-26 | 69.20M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | 69.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 69.69M shares derived: average of 2 quarters · filed 2025-02-26 | 69.68M shares derived: average of 3 quarters · filed 2025-02-26 | 69.64M shares 10-K · filed 2025-02-26 |
| 2022-09-30 | 69.73M shares 10-Q · filed 2023-11-01 | 69.69M shares derived: average of 2 quarters · filed 2023-11-01 | 69.64M shares 10-Q · filed 2023-11-01 | 69.57M shares derived: average of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | 69.64M shares 10-Q · filed 2023-08-02 | 69.59M shares 10-Q · filed 2023-08-02 | 69.51M shares derived: average of 3 quarters · filed 2024-03-05 | 69.50M shares derived: average of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | 69.54M shares 10-Q · filed 2023-05-09 | 69.45M shares derived: average of 2 quarters · filed 2024-03-05 | 69.45M shares derived: average of 3 quarters · filed 2024-03-05 | 74.19M shares derived: average of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | 69.35M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05 | 69.41M shares derived: average of 2 quarters · filed 2024-03-05 | 75.75M shares derived: average of 3 quarters · filed 2024-03-05 | 82.06M shares 10-K/A · filed 2024-03-05 |
| 2021-09-30 | 69.46M shares 10-Q · filed 2022-11-09 | 78.94M shares derived: average of 2 quarters · filed 2022-11-09 | 86.30M shares 10-Q · filed 2022-11-09 | 90.15M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | 88.42M shares 10-Q · filed 2022-07-27 | 94.86M shares 10-Q · filed 2022-07-27 | 97.05M shares derived: average of 3 quarters · filed 2023-02-28 | 98.13M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | 101.36M shares 10-Q · filed 2022-05-05 | 101.36M shares derived: average of 2 quarters · filed 2023-02-28 | 101.36M shares derived: average of 3 quarters · filed 2023-02-28 | 101.35M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | 101.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 101.36M shares derived: average of 2 quarters · filed 2023-02-28 | 101.35M shares derived: average of 3 quarters · filed 2023-02-28 | 101.32M shares 10-K · filed 2023-02-28 |
| 2020-09-30 | 101.36M shares 10-Q · filed 2021-10-27 | 101.34M shares derived: average of 2 quarters · filed 2021-10-27 | 101.31M shares 10-Q · filed 2021-10-27 | 101.28M shares derived: average of 4 quarters · filed 2022-03-17 |
| 2020-06-30 | 101.32M shares 10-Q · filed 2021-07-29 | 101.28M shares 10-Q · filed 2021-07-29 | 101.25M shares derived: average of 3 quarters · filed 2022-03-17 | 101.24M shares derived: average of 4 quarters · filed 2022-03-17 |
| 2020-03-31 | 101.23M shares 10-Q · filed 2021-04-28 | 101.22M shares derived: average of 2 quarters · filed 2022-03-17 | 101.21M shares derived: average of 3 quarters · filed 2022-03-17 | 101.19M shares derived: average of 4 quarters · filed 2022-03-17 |
| 2019-12-31 | 101.20M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17 | 101.19M shares derived: average of 2 quarters · filed 2022-03-17 | 101.18M shares derived: average of 3 quarters · filed 2022-03-17 | 101.15M shares 10-K/A · filed 2022-03-17 |
| 2019-09-30 | 101.19M shares 10-Q · filed 2020-10-28 | 101.17M shares derived: average of 2 quarters · filed 2020-10-28 | 101.13M shares 10-Q · filed 2020-10-28 | 101.09M shares derived: average of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | 101.15M shares 10-Q · filed 2020-07-29 | 101.11M shares 10-Q · filed 2020-07-29 | 101.06M shares derived: average of 3 quarters · filed 2021-02-25 | 101.03M shares derived: average of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | 101.06M shares 10-Q · filed 2020-04-29 | 101.02M shares derived: average of 2 quarters · filed 2021-02-25 | 100.99M shares derived: average of 3 quarters · filed 2021-02-25 | 100.96M shares derived: average of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | 100.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 100.96M shares derived: average of 2 quarters · filed 2021-02-25 | 100.93M shares derived: average of 3 quarters · filed 2021-02-25 | 100.85M shares 10-K · filed 2021-02-25 |
| 2018-09-30 | 100.94M shares 10-Q · filed 2019-10-30 | 100.90M shares derived: average of 2 quarters · filed 2019-10-30 | 100.81M shares 10-Q · filed 2019-10-30 | 102.12M shares derived: average of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | 100.87M shares 10-Q · filed 2019-07-24 | 100.74M shares 10-Q · filed 2019-07-24 | 102.52M shares derived: average of 3 quarters · filed 2020-02-19 | 103.60M shares derived: average of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | 100.60M shares 10-Q · filed 2019-05-01 | 103.34M shares derived: average of 2 quarters · filed 2020-02-19 | 104.51M shares derived: average of 3 quarters · filed 2020-02-19 | 105.28M shares derived: average of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | 106.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | 106.46M shares derived: average of 2 quarters · filed 2020-02-19 | 106.84M shares derived: average of 3 quarters · filed 2020-02-19 | 106.94M shares 10-K · filed 2020-02-19 |
| 2017-09-30 | 106.84M shares 10-Q · filed 2018-10-31 | 107.23M shares derived: average of 2 quarters · filed 2018-10-31 | 107.24M shares 10-Q · filed 2018-10-31 | 107.42M shares derived: average of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | 107.61M shares 10-Q · filed 2018-07-26 | 107.47M shares 10-Q · filed 2018-07-26 | 107.61M shares derived: average of 3 quarters · filed 2019-02-19 | 108.03M shares derived: average of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | 107.49M shares 10-Q · filed 2018-05-04 | 107.61M shares derived: average of 2 quarters · filed 2019-02-19 | 108.17M shares derived: average of 3 quarters · filed 2019-02-19 | 108.97M shares derived: average of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | 107.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | 108.51M shares derived: average of 2 quarters · filed 2019-02-19 | 109.46M shares derived: average of 3 quarters · filed 2019-02-19 | 110.28M shares 10-K · filed 2019-02-19 |
| 2016-09-30 | 109.28M shares 10-Q · filed 2017-11-03 | 110.32M shares derived: average of 2 quarters · filed 2017-11-03 | 111.13M shares 10-Q · filed 2017-11-03 | 112.12M shares derived: average of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | 111.36M shares 10-Q · filed 2017-08-08 | 112.00M shares 10-Q · filed 2017-08-08 | 113.06M shares derived: average of 3 quarters · filed 2018-02-23 | 113.74M shares derived: average of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | 112.48M shares 10-Q · filed 2017-05-05 | 113.91M shares derived: average of 2 quarters · filed 2018-02-23 | 114.54M shares derived: average of 3 quarters · filed 2018-02-23 | 114.74M shares derived: average of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | 115.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | 115.57M shares derived: average of 2 quarters · filed 2018-02-23 | 115.49M shares derived: average of 3 quarters · filed 2018-02-23 | 115.37M shares 10-K · filed 2018-02-23 |
| 2015-09-30 | 115.79M shares 10-Q · filed 2016-11-03 | 115.56M shares derived: average of 2 quarters · filed 2016-11-03 | 115.38M shares 10-Q · filed 2016-11-03 | |
| 2015-06-30 | 115.33M shares 10-Q · filed 2016-08-04 | 115.10M shares 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | 114.66M shares 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | 112.06M shares 10-K · filed 2017-02-28 | |||
| 2013-09-30 | 106.92M shares 10-Q · filed 2013-11-01 | 102.26M shares derived: average of 2 quarters · filed 2013-11-01 | 100.32M shares 10-Q · filed 2013-11-01 | 99.18M shares derived: average of 4 quarters · filed 2013-11-01 |
| 2013-06-30 | 97.60M shares 10-Q · filed 2013-08-01 | 96.96M shares 10-Q · filed 2013-08-01 | 96.60M shares derived: average of 3 quarters · filed 2013-08-01 | 96.21M shares derived: average of 4 quarters · filed 2013-11-01 |
| 2013-03-31 | 96.38M shares 10-Q · filed 2013-05-01 | 96.10M shares derived: average of 2 quarters · filed 2013-05-01 | 95.74M shares derived: average of 3 quarters · filed 2013-11-01 | 94.10M shares derived: average of 4 quarters · filed 2013-11-01 |
| 2012-12-31 | 95.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | 95.42M shares derived: average of 2 quarters · filed 2013-11-01 | 93.34M shares derived: average of 3 quarters · filed 2013-11-01 | 90.91M shares 10-K · filed 2013-02-26 |
| 2012-09-30 | 95.03M shares 10-Q · filed 2013-11-01 | 92.10M shares derived: average of 2 quarters · filed 2013-11-01 | 89.27M shares 10-Q · filed 2013-11-01 | 87.66M shares derived: average of 4 quarters · filed 2013-11-01 |
| 2012-06-30 | 89.17M shares 10-Q · filed 2013-08-01 | 86.38M shares 10-Q · filed 2013-08-01 | 85.21M shares derived: average of 3 quarters · filed 2013-08-01 | 84.53M shares derived: average of 4 quarters · filed 2013-08-01 |
| 2012-03-31 | 83.59M shares 10-Q · filed 2013-05-01 | 83.23M shares derived: average of 2 quarters · filed 2013-05-01 | 82.98M shares derived: average of 3 quarters · filed 2013-05-01 | 82.69M shares derived: average of 4 quarters · filed 2013-05-01 |
| 2011-12-31 | 82.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | 82.68M shares derived: average of 2 quarters · filed 2013-02-26 | 82.39M shares derived: average of 3 quarters · filed 2013-02-26 | 82.05M shares 10-K · filed 2013-02-26 |
| 2011-09-30 | 82.49M shares 10-Q · filed 2012-10-31 | 82.15M shares derived: average of 2 quarters · filed 2012-10-31 | 81.78M shares 10-Q · filed 2012-10-31 | 80.35M shares derived: average of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | 81.81M shares 10-Q · filed 2012-08-01 | 81.42M shares 10-Q · filed 2012-08-01 | 79.64M shares derived: average of 3 quarters · filed 2013-02-26 | 78.16M shares derived: average of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | 80.85M shares 10-Q · filed 2012-05-02 | 78.55M shares derived: average of 2 quarters · filed 2013-02-26 | 76.94M shares derived: average of 3 quarters · filed 2013-02-26 | 76.03M shares derived: average of 4 quarters · filed 2013-02-26 |
| 2010-12-31 | 76.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | 74.99M shares derived: average of 2 quarters · filed 2013-02-26 | 74.42M shares derived: average of 3 quarters · filed 2013-02-26 | 72.07M shares 10-K · filed 2013-02-26 |
| 2010-09-30 | 73.73M shares 10-Q · filed 2011-11-02 | 73.50M shares derived: average of 2 quarters · filed 2011-11-02 | 70.67M shares 10-Q · filed 2011-11-02 | |
| 2010-06-30 | 73.28M shares 10-Q · filed 2011-08-03 | 69.12M shares 10-Q · filed 2011-08-03 | ||
| 2009-12-31 | 63.03M shares 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |